Is home monitoring safe for early diabetic eye problems?
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether monitoring certain diabetic eye changes in the community is as safe as hospital checks. It's for people with early signs of diabetic eye disease that haven't yet reached a more advanced stage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes and have been referred to hospital eye services for possible diabetic maculopathy or pre-proliferative retinopathy.
- You are 18 years or older.
- You do not have diabetic macular oedema (swelling in the center of the retina).
- You do not have proliferative diabetic retinopathy (advanced new blood vessel growth).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a treatment aimed at preventing or slowing early diabetic eye disease in people with mild, early changes. You may be considered if your diabetes is moderately controlled and your eye tests show early warning signs.
This study closely follows people with type 2 diabetes who have early signs of diabetic retinopathy (damage to the retina from diabetes) to see how the condition changes over time. It does not test a new treatment but monitors the eye's health closely. It may be a good fit if you have diabetic retinopathy that does not need immediate treatment.
This trial tests if a special eye exam (electroretinogram) done by a nurse can find early signs of diabetic retinopathy in people with diabetes who have no known eye problems yet. It aims to make screening easier and more accessible.
This study uses special eye photographs to look at early signs of diabetes damage in the eyes and kidneys. It may help doctors predict how diabetes complications progress and plan better care.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.